cJun is a major component of the transcription factor AP-1 and mediates a diverse set of biologic properties including proliferation, differentiation, and apoptosis. To identify cJun-responsive genes, we inducibly expressed cJun in Rat-1a cells and observed two distinct phenotypes: changes in cellular morphology with adherent growth and anchorage-independent growth. The biologic effects of cJun were entirely reversible demonstrating that they require the continued presence of cJun. To determine the genes, which mediate the biologic effects of cJun, we employed multiple methods including differential gene analysis, suppression subtractive hybridization, and cDNA microarrays. We identified 38 cJun-responsive genes including three uncharacterized genes under adherent and/or nonadherent conditions. Half of the known 36 genes were cytoskeleton-and adhesion-related genes, suggesting a major role of cJun in the regulation of the genes related to cell morphology. As proof of the principle that this approach could identify genes whose upregulation was necessary for nonadherent growth, we investigated one gene, stathmin whose upregulation by cJun was observed only under these conditions. Although overexpression of stathmin did not result in nonadherent growth, inhibition of stathmin protein expression by antisense oligonucleotides in cJun-induced Rat-1a cells prevented nonadherent growth. These results suggest that stathmin plays an essential role in anchorage-independent growth by cJun and may be a potential target for specific inhibitors for AP-1-dependent processes involved in carcinogenesis.
Introduction c-jun is the cellular homolog of the oncogene v-jun, which was originally identified as the transforming sequence of avian sarcoma virus 17 (Bohmann et al., 1987; Maki et al., 1987) . cJun is a nuclear phosphoprotein, which is the central component of the transcriptional complex AP-1. AP-1 consists of homodimers and heterodimers of the Jun and Fos gene family members and regulates transcription through AP-1 and cAMP responsive elements (Angel et al., 1987 (Angel et al., , 1988 Curran and Franza, 1988; Sassone-Corsi et al., 1990) . Many extracellular stimuli rapidly activate and induce cJun through well-characterized cytoplasmic signaling cascades to presumably activate cJun target gene transcription (Karin, 1996; Liu et al., 1996; Whitmarsh and Davis, 1996) .
The role of cJun in human cancers remains to be defined. Substantial evidence suggests that cJun is necessary for cellular proliferation and transformation. Deregulated expression of cJun induces immortalized rat fibroblasts to grow in a nonadherent fashion (Schutte et al., 1989) . cJun expression is constitutive in rodent fibroblasts transformed by activated c-H-ras and raf-1 while c-fos expression is attenuated suggesting that cJun homodimers are critical in the transformation pathway (Siegfried and Ziff, 1990; Kolch et al., 1993; Osei-Frimpong et al., 1994; Rapp et al., 1994) . Stable expression of a transactivation deletion mutant of c-jun in malignant mouse epidermal cell lines inhibited tumor formation in nude mice (Domann et al., 1994) . Furthermore, a dominant negative mutant of c-jun inhibits growth and transformation of rodent fibroblasts by H-ras, raf-1, mos, c-myc, c-fos and SV40 T antigen (Rapp et al., 1994) .
Although recent research has revealed the signaling cascades, which modulate cJun/AP-1 activity, most of its downstream effector genes remain to be identified. To identify cJun-responsive genes associated with nonadherent growth, we established a conditional system of Rat-1a cells using tetracycline-inducible cJun, which was sufficient to produce two distinct phenotypes: morphological alterations and anchorage-independent growth. Using differential display, suppression-subtracted hybridization (SSH), and cDNA microarrays, we identified 38 genes, which were differentially expressed under cJun induction. Of the 38 cJun-responsive genes, three were unknown genes and half were cytoskeleton-and adhesion-related genes whereas only two genes, stathmin and p55cdc, were identified as growth-related genes. For proof of the principle that this approach can identify cJun gene targets, which are critical for biologic activity, we demonstrate that deregulated expression of stathmin by cJun necessary for cJun-mediated anchorage-independent growth.
Results

Infection of Rat1a cells with an amphotrophic retrovirus expressing a doxycycline-inducible c-jun produces reversible biologic effects
We constructed amphotrophic retroviruses containing doxycycline-inducible cJun and the cJun transactivation mutant, TAM67, by inserting each gene into pLRT (Watsuji et al., 1997) . After infection of RAT1a cells with pLRT-c-jun and pLRT-TAM67 and drug selection, clones expressing inducible cJun and TAM67 were isolated. Rat1a-Jun2 and TAM67-8 cells showed 20-fold induction of c-jun and TAM67 mRNA, respectively (Figure 1a) . The induction of c-jun and TAM67 was observed at as little as 50 ng/ml of doxycycline and reached a maximum at 2 mg/ml (Figure 1b ). c-jun mRNA in the Rat1a-Jun2 clone increased within 1 h after induction and reached a maximum by 4 h (Figure 1c) . After washing out the doxycycline, c-jun rapidly returned to its basal level in 8 h. cJun protein expression also rapidly increased to the maximum within 4 h and sustained its level for as long as 14 days without further addition of doxycycline (Figure 1d ). Similar induction kinetics was observed for TAM67 in TAM67-8 cells.
To determine phenotypic changes by cJun under adherent growth conditions, the cells were observed under microscope. After 6 days of induction, the Jun-2 cells became elongated and piled up. These changes were not observed in cells expressing the c-jun mutant, TAM67 (Figure 2 ). To determine the relation of cJun induction and its biologic effects, a time course of induction was conducted. Although cJun expression reached a maximum by 4 h after induction, morphological changes were only observed by 24 h with the cells becoming spindle shaped and refractile. Within 2 days, the cells aggregated to each other and by 3 days of doxycycline treatment showed significant piling up (Figure 3a) . Thus, cJun morphologic alterations required an extended period of expression of cJun. After washing out the doxycycline, partial reversion of morphological aberrations started in 24 h and complete reversion was observed after 2-3 days (Figure 3a) . Thus, the induction and maintenance of the morphologic alterations required the continued presence of increased cJun expression. To assess whether cJun expression affected cellular growth, MTT assays under adherent conditions were performed. Growth stimulation by cJun was observed in 2% serum but not in 10 or 1% serum, while increased density saturation was observed in 10% serum (Figure 3b ).
To determine whether cJun expression produced nonadherent cell growth, cells were grown in soft agarose with or without doxycycline. Several Rat1a-Jun2 clones showed anchorage-independent growth after induction of cJun (Figure 3c ). Rat1a parental cells and Rat1a-GFP cells did not show anchorage-independent growth in the absence and presence of doxycycline ( Figure 3c and data not shown). To determine if cJuninduced nonadherent cell growth is reversible, we isolated individual subclones from Rat1a-Jun-2 cells grown in soft agarose in the presence of doxycycline and passaged them in adherent conditions without doxycycline for several generations. These subclones were then subjected to cloning in soft agarose. All the subclones demonstrated doxycycline-inducible nonadherent growth demonstrating that in this assay, cJun-induced nonadherent growth was completely dependent upon the presence of elevated levels of cJun ( Figure 3d ).
Use of different techniques to isolate differentially expressed genes to identify cJun-responsive genes
To identify differentially expressed genes, which mediate the biologic effects of cJun, we used three different techniques: differential display, SSH followed by reverse Northern blot analysis, and microarray analysis (as described in Material and methods, 
Validation of 38 genes as c-jun responsive
We validated 38 genes as up-or downregulated by cJun including three clones with no homology to the current database ( Figure 4 and Table 2 ) in addition to c-jun itself. We searched for promoter sequences of the 36 known genes through GenBank and PubMed and analysed them for AP-1 and ATF binding sites using the transcription factor database TRANSFAC (Wingender et al., 2000) . The promoters for 20 genes have been reported and all contain AP-1 and/or ATF (like) sites. Eight genes including fit-1, TGFb, lamin A, and collagen type 1 a1 have been reported to be regulated by AP-1. The presence of AP-1 or ATF sites in all the reported promoters and documented AP-1 regulation of some genes suggest that the identified genes may be direct transcriptional targets of cJun.
cJun-responsive genes are functionally diverse and are differentially regulated in adherent and nonadherent conditions
The c-jun-responsive genes we identified are functionally diverse including genes involved in signal transduction, (Table 2) . Interestingly, half of the known 36 genes were cytoskeleton-and adhesion-related genes, suggesting a major role for cJun in the regulation of the genes related to cell morphology, adhesion, and motility. Of further note, many of the cJun-responsive genes were differentially regulated under adherent and nonadherent conditions. In contrast, only two genes, stathmin and p55cdc, were identified as growth-related genes and their up-regulation by cJun was observed only under nonadherent conditions. Time-course experiments under nonadherent conditions showed that stathmin expression in Rat1a cells was decreased after culturing the cells under nonadherent conditions and that cJun increased the expression in 8 h (Figure 5a ).
Increased expression of stathmin by cJun is necessary but not sufficient for anchorage-independent growth
To determine the role of stathmin on nonadherent growth mediated by cJun, we treated cJun-induced Rat1a cells under nonadherent conditions with antisense Inducible and reversible anchorage-independent growth by cJun in soft agarose. Colonies larger than 50 mm were counted by autocounter in the same area of each dish (n ¼ 3). These colonies of Jun-2 cells with doxycycline were independently isolated (Jun-2-2, -3 and -4), expanded without doxycycline, and subjected to the same assay Figure 5b ). This caused a significant decrease in cJunmediated nonadherent growth compared with nonsense PON control ( Figure 5b ). We next tested whether the overexpression of stathmin was sufficient for nonadherent growth by using Rat-1a clones with a high level of inducible stathmin expression. However, stathmin overexpression did not induce anchorage-independent growth in any clone ( Figure 6 ). These results suggest that deregulated expression of stathmin by cJun is necessary but not sufficient for cJun-induced anchorageindependent growth.
Stathmin is upregulated by cJun at ATF and E2F sites
To determine the mechanism of the increased expression of stathmin, we determined transcriptional activity using a stathmin promoter linked to the luciferase gene. The proximal region of the stathmin promoter contains two E2F sites, two Sp-1 sites and two ATF-like sites (Melhem et al., 1991b) (Figure 7 ). The activity of this stathmin promoter fragment was increased threefold by cJun in the nonadherent conditions ( Figure 6b ). While the mutation of the SP1 sites has no effect, mutation of two E2F sites decreased the promoter activity by 60% and that of two ATF-like sites by 20%. These results suggest that cJun increased stathmin promoter activity through two E2F sites and partly by two ATF-like sites.
Discussion
We have developed a reversible biologic assay system using doxycycline-inducible cJun in Rat1a cells under adherent and nonadherent conditions. Using three different techniques, we systematically identified 38 genes regulated by cJun. Half of the genes were identical to or showed homology to cytoskeleton-and adhesionrelated genes, suggesting their possible cooperative roles in the cJun-induced cellular morphologic changes. Although only two genes, stathmin and p55cdc, were identified as growth-related genes, the increased expression of stathmin was necessary for cJun-mediated anchorage-independent growth.
Conditional biologic effects induced by c-jun reflects transcriptional activity
The use of a tightly controlled inducible expression system allowed us to determine the effects of c-jun on cellular growth and morphology. The reversible nature of the changes and the requirement of the transactiva- Hosoya et al. (1996) ; Melhem et al. (1991) n.r. et al., 1995) against the transcription factor database Transfac (Liu et al. 1999) and selected the consensus sequences of AP-1 (tgactca) and ATF (tgacgtca) sites and homologous sequences with one or two base pair mismatches Location of the first base of core sequence of AP-1/ATF sites. Numbering is from the major transcription initiation site as +1. MAI, microarray of Incyte, SSH, subtractive suppression hybridization, MAR, microarray of Research Genetics, DD, differential display; n.r., not reported tion domain strongly support that the cellular effects are the result of cJun transcriptional activity. In addition, the delay of the morphological changes after cJun induction is similar to morphological transformation by vJun and cFos, which starts after 24 h and is complete in 2-3 days (Miao and Curran, 1994; Bader et al., 2000) . We also observed that different phenotypes required different times of cJun overexpression; spindle and refractile phenotype required 24 h, close contact of cells required 2 days and the piling up of cells needed 3 days. The temporal nature of these phenotypic changes suggests that c-jun causes alterations of cytoskeleton and cell adhesion in a time-dependent manner through direct or indirect transcriptional regulation of multiple genes related to the cytoskeleton and adhesion. Inducible cell growth by cJun using PolyHEME-treated dishes enabled us to analyse gene expression in nonadherent conditions mimicking anchorage-independent growth in soft agarose, a pivotal phenotype of malignant transformation.
Identification of CJun-responsive genes
Screening for cJun responsive genes
We conducted a direct comparison of three different strategies to screen for differentially expressed genes. Each technique has unique advantages and disadvantages. While differential display was relatively easy to conduct needing minimal amount of RNA and effort, the specificity of the technique was very low requiring extensive validation of all fragments identified. Optimization of SSH gave considerably better results with a specificity approaching 30%. However, SSH requires large amounts of RNA and all clones needed to be screened with the reverse Northern technique to ensure a high specificity. cDNA microarrays require reasonable amounts of RNA, are easy to use, and provided a high sensitivity and specificity. However, confirmation was still required and the procedure is more costly than the other approaches.
Identification of cJun-responsive genes
Although a number of AP-1-regulated genes have been described, systematic screening for cJun-responsive genes related to biologic activity has not been performed. Potential cJun/AP-1 target genes such as transin, collagenase, metallothionein, proliferin, and nerve growth factor have been identified by analysing functional AP-1-binding sites in their promoters by in vitro mutagenesis and transient cotransfection experiments (Angel and Karin, 1991) . More recently, other approaches to screen differentially expressed genes in cells with or without overexpressed AP-1 components identified Fra-1, Fit-1, annexin II and V and dnmt1 as cfos target genes in rat fibroblasts (Braselmann et al., 1992; Bakin and Curran, 1999) , and bkj, glutaredoxin, (Hartl and Bister, 1995; Goller et al., 1998; Hadman et al., 1998; Fu et al., 1999; Bader et al., 2001; Hartl et al., 2001) . It is noteworthy that dnmt1, identified as a cFos target gene, induces morphological transformation in rat fibroblasts and that the inhibition of its expression can revert c-fos transformation (Bakin and Curran, 1999) . Heparin-binding EGF, JAC and TOJ3 identified as vJun target genes also have partial transformation activity in avian fibroblasts (Fu et al., 1999; Bader et al., 2001; Hartl et al., 2001) . Target genes of cFos and vJun, however, may be considerably different from those of cJun. For example, vJun has a dominant negative effect on a TRE-controlled promoter activated by cJun, while vJun transactivates a CREcontrolled promoter more than cJun does (Gao et al., 1996) . Knockout mice and cell lines deficient in c-jun and c-fos show completely different phenotypes, suggesting that cJun and cFos may regulate different target genes and thus execute distinct biological functions (Karin et al., 1997) . In addition, transformation by ras and raf-1 cause constitutive cJun expression, but undetectable cFos expression (Siegfried and Ziff, 1990; Kolch et al., 1993; Osei-Frimpong et al., 1994; Rapp et al., 1994) and transformation by ras, raf-1, mos, c-myc, c-fos, and SV40 T antigen can be inhibited by dominant negative cJun (Rapp et al., 1994) , suggesting that cJun may mediate multiple oncogenic pathways. Therefore, c-jun-specific target genes might be potential therapeutic targets for diverse cancers and identification of such genes is highly important.
We identified 38 cDNA clones that correlated with anchorage-independent growth by c-jun. Although some might be indirect targets of c-jun, the existence of AP-1 and/or ATF (like) elements in 19 known promoters and the reported AP-1 regulation of several genes suggest that a number of them may be direct targets. It is noteworthy that as many as half of the 36 known genes were identical or similar to cytoskeletal-and adhesionrelated genes. These results suggest that cJun causes morphological transformation through direct or indirect transcriptional regulation of multiple genes related to the cytoskeleton and cell adhesion. The cytoskeletaland adhesion-related genes with the exception of collagen alpha 1 type 1 (Noti et al., 1996) , annexin II (Braselmann et al., 1992) , lamin A (Tiwari et al., 1998) and integrin alpha (also named p150 and CD11c) Lopez-Rodriguez et al., 1996; Noti et al., 1996) , galectin 3 (Gaudin et al., 1997) , and annexin I (Solito et al., 1998) represent novel targets of AP-1. These genes may cooperatively contribute to the observed morphological phenotypes by cJun. For example, several genes were Figure 7 Regulation of stathmin promoter by cJun under nonadherent conditions. (a) The proximal region of the stathmin promoter contains two ATF-like sites, two E2F sites and two Sp-1 sites (boxes) adjacent to a CCAAT box (underline). Mutations were created in these sites by site-directed mutagenesis as indicated under wild type sequences. Each mutated sequence corresponds to a restriction enzyme site as described in Material and methods. (b) Rat-1a cells were cotransfected with wild-type or mutant stathmin promoterluciferase reporter gene constructs and the wild-type cJun expression vector or control vector. A renilla luciferase vector was also cotransfected to correct for transfection efficiency. At 1 day after transfection, cells were trypsinized and plated on Poly-HEME-treated dishes. After 24 h culture under nonadherent conditions, cells were lysed and luciferase activity assayed shown to be involved in actin organization. Filamin A/ actin binding protein-280, a basic isoform of filamin C, was shown to bind to integrin b1 or b2 subunits and to anchor actin filaments to the cell membrane (Sharma et al., 1995; Loo et al., 1998) . Integrin b2 forms a complex with the integrin ax subunit that causes a redistribution of cytoskeletal proteins and actin polymerization (Mazzone and Ricevuti, 1995) . Ost g, a guanine-nucleotide exchange factor for Rho family members, affects the organization of actin filaments (Horii et al., 1994; Lorenzi et al., 1999) . The present data together with the reported functions of those genes suggest that multiple genes related to the cytoskeleton and adhesion may play cooperative roles in the morphological phenotypes induced by Jun.
Increased expression of stathmin required for anchorage-independent growth by cJun
We screened for cJun-responsive genes using Rat 1a cells under nonadherent growth conditions. As such, one might expect that some of the genes would be necessary for the nonadherent growth of cJun-expressing Rat1a cells. This should be particularly true for those genes, which are regulated, in a unique fashion in nonadherent conditions. As a proof of principle, we focused on one such gene, stathmin. Stathmin (Sobel et al., 1989) , also designated p19 (Schubart et al., 1992) , Op18 (Hailat et al., 1990) and prosolin (Cooper et al., 1991) , is an abundant cytosolic phosphoprotein whose expression and phosphorylation is modulated during the activation of a number of signal transduction pathways (Sobel, 1991) and linked to cell differentiation and proliferation (Cooper et al., 1990; Doye et al., 1992; Koppel et al., 1993; Balogh et al., 1996; Di Paolo et al., 1996) . The expression of stathmin is increased in a wide variety of cancer cells and specimens (Brattsand et al., 1993; Ghosh et al., 1993; Luo et al., 1994; Nylander et al., 1995; Bieche et al., 1998) , suggesting that it may play a role in the process of malignant transformation. Stathmin has been recently shown to interact with and sequester free tubulin leading to the depolymerization of microtubules (Belmont and Mitchison, 1996; Marklund et al., 1996) . Our results are consistent with the reported cell proliferation property of stathmin since treatment with antisense oligonucleotides inhibited nonadherent growth. Interestingly, the increased expression of stathmin was restricted to nonadherent conditions, which may manifest transformation status more than adherent conditions. Although several oncogene-transformed cells do not have increased stathmin expression or proliferation under adherent conditions (Mistry and Atweh, 1999) , the effect of such oncogenes on stathmin expression under nonadherent conditions was not reported. Our results suggest that differential screening only using adherent conditions may miss genes involved in cellular properties such as nonadherent growth. Although stathmin alone was not sufficient to induce nonadherent growth of Rat1a cells, the necessity of its increased expression suggests that stathmin could be a potential target for specific inhibitors of AP-1 dependent process involved in carcinogenesis.
The increase in promoter activity of stathmin by cJun suggests that stathmin expression is regulated by transcription, consistent with a previous report (Mistry et al., 1995) . The proximal promoter of stathmin contains a ccaat box and several potential transcription-factor-binding sites (Melhem et al., 1991a; Hosoya et al., 1996) . Our mutational analysis results suggest that stathmin promoter activity was increased mainly by two E2F sites and partly by two ATF-like sites in Rat-1a cells overexpressing cJun. cJun as well as vJun were reported to increase E2F activity by deregulating retinoblastoma protein phosphorylation as a consequence of enhanced G1 cyclin-cdk activity (Schreiber et al., 1999; Clark et al., 2000) . These indirect mechanisms might be involved in transactivation of stathmin by cJun under nonadherent conditions in this system. In addition, the partly activated ATF-like sites suggest the involvement of direct activation of stathmin promoter by an AP-1 complex containing cJun.
In conclusion, we have established a relevant conditional biologic system under adherent and nonadherent growth conditions to screen for cJun target genes. The regulation of multiple cytoskeleton-and adhesionrelated genes by cJun suggests their possible cooperative roles in morphological transformation. A growthrelated gene, stathmin, was necessary for cJun-mediated anchorage-independent growth. Genes such as stathmin could be potential targets for specific inhibitors of AP-1-dependent processes involved in carcinogenesis and should be further identified and characterized.
Materials and methods
Plasmids
Plasmid pLRT-GFP contains all the components of the reverse tetracycline-regulated (rtTA) system, a drug selectable marker of blasticidin D deaminase, the internal ribosome entry site and the gene of interest (GFP) as described elsewhere (Watsuji et al., 1997) . The plasmid pLRT-c-jun was constructed by subcloning the entire coding region of c-jun cDNA from the pGEM-c-jun (Brown et al., 1993) into the parental pLRT vector. Full length stathmin cDNA in pMEP4-stathmin plasmid (a generous gift from Dr M. Gullberg) (Larsson et al., 1999) was also subcloned into the pLRT vector.
To construct the stathmin/Op18/pr22 promoter-luciferase reporter gene plasmid, a 1.4 kb XbaI and SacI fragment of stathmin genomic DNA consisting of 0.8 kb upstream of the transcription-initiation site and 0.6 kb of noncoding exon 1 and intron 1 from pUC-pr22 (a generous gift from Dr T Marunouchi) (Melhem et al., 1991b; Hosoya et al., 1996) was subcloned into the pGL3 basic vector. The 0.9 kb XhoI and SacI fragment containing 0.3 kb upstream of the transcriptioninitiation site was subcloned into pGL3 basic vector. This region contains two Sp-1 sites, two ATF-like sites, and two E2F sites (Melhem et al., 1991b) and site-directed mutagenesis of these sites was performed using the GeneEditor in vitro sitedirected mutagenesis system (Promega, Madison, WI, USA) according to the manufacturer's recommendations. Briefly, double-stranded plasmids containing stathmin promoters were alkaline denatured, annealed with one or two mutagenic oligonucleotides and a selection oligonucleotide that gives new resistance against antibiotic selection mix (Promega). Mutant strands were synthesized with T4 DNA polymerase and T4 DNA ligase. BMH 71-18 mutS competent cells were transformed with the mutagenesis reaction and grown overnight with the antibiotic selection mix. With isolated plasmid DNAs, JM109 competent cells were then transformed and grown on LB plates containing ampicillin and the antibiotic selection mix. The mutant clones were confirmed by restriction enzyme reactions against introduced mutations described below. The following oligonucleotides were used for mutagenesis (substituted bases are underlined):
ATF-like site: (+2) TTGGTGCTCAGAGTGCTC-GAGGGCGGCTCGGACTGAG (+38) ATF-like site: (À59) CGGAGCCCCGCGCGGCTC-GAGCGTGCCTCTGTTTGG (À24) Two E2F sites: (À42) GTCACGTGCCTCTGTAAGCTTCTTAATATT-GCGCCCGGGTCTGTTG (+4) Two E2F sites for ATF-like site-mutated promoter:
Two Sp-1 sites:
To facilitate the identification, these sites were replaced with restriction enzyme sites (CTCGAG is XhoI site; AAGCTT, HindIII; AATATT. SspI; TTTAAA. DraI) (see Figure 7) .
Cell lines and culture
The immortal line of nonmalignant Fisher rat fibroblasts, Rat1a, were described previously (Schutte et al., 1989) . Unless otherwise indicated, the cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% FBS, penicillin (100 U/ml) and streptomycin (100 mg/ml).
To establish inducible GFP-, cJun-, TAM67-and StathminRat-1a clones, pLRT-GFP, -c-jun, -TAM67, and -stathmin were transfected into packaging Phoenix A cells, retrovirus harvested, and used to infect Rat1a cells as described elsewhere (Watsuji et al., 1997) . Stable transfectants were selected by blasticidin at 5 mg/ml and screened by Northern and Western blot analyses for inducibility of cJun, TAM67, and stathmin expression in response to doxycycline. Rat-1a J2 and Rat1aTAM67-8 clones were chosen because of their high induction and low leakiness of cJun and TAM67 expression. Several clones with various expression levels of stathmin were also chosen.
Cell growth assays
Cell growth was measured in 96-well plates using an MTT (dimethyl thiozolyl-2 0 , 5 0 -diphenylo-2-H-tetrazolium bromide)-based assay (nonradioactive proliferation assay, Promega Corp., Madison, WI, USA) as described previously (Sabichi et al., 1998) . Anchorage-independent growth assays were performed using 0.35% soft agarose (Seaplaque) in six-well plates as described previously (Sabichi et al., 1998) . Colonies more than 50 mm in diameter were autocounted with an Omnicon 3600 image analysis system (Imaging Products International, Chantilly, VA, USA). To mimic the anchorage-independent growth in soft agarose, cells were grown on poly(2-hydroxyethyl methacrylate) (poly-HEME) (SIGMA)-treated dishes essentially as described elsewhere (Szabo et al., 1998) . The number of viable cells were counted using microscopy after trypan blue staining, or measured with the MTT-based assay.
Western blot analysis
Purified total protein (50 mg) isolated from subconfluent cells or from suspended cells was separated by SDS-PAGE, transferred to nitrocellulose membranes and reacted with anti-cJun (AP-1/AB-1, Oncogene Science) and anti-stathmin (Calbiochem) antibodies. The primary antibodies were detected using anti-rabbit antibody conjugated with horseradish peroxidase and visualized using the Amersham ECL system after washing with TBST six times (5 min each) after first and second antibodies incubation.
RNA
The total RNA was isolated from subconfluent cells or from suspended cells by the GITC/CsCl ultracentrifugation method. mRNA was purified from total RNA with an mRNA purification kit (QIAGEN) for SSH and microarray analysis. Total RNA was also prepared with an RNA purification kit (QIAGEN) for some experiments.
Northern blot analysis
Total RNA (1 mg) was electrophoresed on agarose gels, transferred to Nytran membranes and hybridized with a [ 32 P]-dCTP-labeled c-jun fragment or cloned cDNA fragments identified by differential expression.
Differential display
RT-PCR was performed using various combinations of anchored and arbitrary primers from the HIEROGLYPH mRNA Profile Kit (GENOMYX) and separated on a denaturing gel according to the manufacturer's recommendations. Selected cDNA fragments were amplified and subcloned into pCR2.1 using the TA-cloning kit (Invitrogen).
SSH
A representative subtracted cDNA library from induced and uninduced cJun Rat-1a cells was constructed using the PCRSelect cDNA subtraction kit (Clontech) according to the manufacturer's recommendations except for modifications of tester and driver ratio (1:30, 1:60 and 1:120). The cDNA library was subcloned into pCR2.1 using the TA-cloning kit. Randomly picked clones were screened by reverse Northern blot analysis. Briefly, individual clones were grown overnight in 96-well plates and the inserts were amplified by PCR. PCR solution (1 ml) was spotted on duplicate Nytran filter and hybridized separately to equal amounts of [ 32 P]-dCTP-labeled cDNA made from RNA isolated from induced and uninduced Jun-2 cells. The filters were washed twice in 2 Â SSC at 421C, twice in 0.1 Â SSC at 421C and exposed to X-ray film at À701C.
Microarray analysis
mRNA from induced and uninduced cJun Rat-1a cells was labeled with Cy5 and Cy3, respectively, by an RT reaction, and hybridized with the Mouse GEM 1 Microarray (Incyte). Corrected signal intensity ratios were calculated using GEMTools software. Total RNA from these cells was also labeled with 33 P by RT reaction, hybridized with a filter micro array (Research Genetics) and analysed with a Phosphoimager. Corrected signal intensity ratios were calculated with Pathway 2 software.
Antisense experiments
Induced Rat-1a cells grown under nonadherent conditions were treated with antisense oligonucleotides against stathmin (5 0 -CTCCAGCTCTTTCACCTG-3 0 ) or with nonsense sequence (5 0 -CTTCCCACTGCTCGCTAT-3 0 ) identical to those used previously (Di Paolo et al., 1996; Howell et al., 1999) . Rat-1a-Jun2 cells were plated on Poly-HEME-treated 96-well plates in the presence of doxycycline and 10 mm HPLC-purified stathmin antisense or nonsense PONs for 24 h. PONs 4 mm were then added every 24 h to respective cultures for an additional 5 days. Previous studies demonstrated that such treatment was necessary to reduce stathmin expression (Di Paolo et al., 1996; Howell et al., 1999) . Cell growth was measured using MTT assays as described previously (Sabichi et al., 1998) except that the reaction was carefully transferred to new 96-well plates to omit the effect of Poly-HEME on optical density measurements. All assays were performed in triplicate and each experiment was repeated at least three times.
Transient transfection and luciferase assay
Cells (2.5 Â 10 5 ) were plated in six-well plates. The following day, cells were transfected with 1 mg of various stathmin promoter-pGL3 plasmids described above and either pCMVjun or pCMV control vector using Fugene 6 (BoehringerMannheim). To correct for transfection efficiency, 10 ng of a renilla luciferase plasmid was also cotransfected. After 24 h, cells were trypsinized and one-tenth of the cells were plated in Poly-HEME-treated six-well dishes. The cultures were grown for a further 48 h under the nonadherent conditions. Protein lysates obtained were extracted according to the manufacturer's instructions (Promega) and the luciferase activity was measured with a luminometer. All assays were performed in triplicate and each experiment was repeated at least three times.
